pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-569 |
Genomic Coordinates | chr3: 171106664 - 171106759 |
Synonyms | MIRN569, hsa-mir-569, MIR569 |
Description | Homo sapiens miR-569 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-569 | |||||||||||||||
Sequence | 61| AGUUAAUGAAUCCUGGAAAGU |81 | |||||||||||||||
Evidence | Experimental | |||||||||||||||
Experiments | SAGE | DRVs in miRNA |
|
|||||||||||||
SNPs in miRNA |
|
|||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | PARD6B | ||||||||||||||||||||
Synonyms | PAR6B | ||||||||||||||||||||
Description | par-6 family cell polarity regulator beta | ||||||||||||||||||||
Transcript | NM_032521 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on PARD6B | |||||||||||||||||||||
3'UTR of PARD6B (miRNA target sites are highlighted) |
>PARD6B|NM_032521|3'UTR 1 AACCGTGGTTTGAATGTTTTCAGAGTGAGGATGCCATGAGGACTTGTACATTTGGCTAGTTTAAAAGCATATATACCTCT 81 GACCAGTGACGTGGAATAGGCATGAGACGAGTAACGTTGCAAGCTTACAATATTATTAAAGTAGTAGTTTGATAATTGTT 161 AATATAAACTTTGGTGGATCAGAGGTGAATTTAAGTCCAAAACAAAGGGGCCTTTGCTGATGAAGTTACGTGCTTTTGCT 241 GTTTTGTCTGTGGAGAATCAGATGTTAAAGCACATTCTTGGAACTATGTGAGAAGACTAGATCATTTCTGTTGGAAGTGG 321 TTGCATATTTAACCTGCTGTGCAGAGCCCAGTTAATTTTTCCTTTAACTGTATTTTTAAAATTCTAATGTGAAGTCTGAT 401 TCTCTCTTGTGGTACATTGGGGACCTCAGCTCTTAAAGGTCTCATGTTCCCAATATTTTATTTTGATTTTTTTTTTTTTT 481 TTTTTTTTTTTTTTTTTTAGTGACTGGGTCTCACTCTGTTGCCCACACTGGAATGCAGTGGCATGATCACAGCTCTCTGC 561 AGCCTCAATCCCCTGGGCTCAAGCAGTCCTCCCACCTCAGCCTCCTGAGTAGCTGGGACCATAGGCACATACCACCACAT 641 CTGTCTACTTTTTGTATTTTTTGTAGAGACAGGGTTTCGCCATGTTGCCCAAGTTGGTCTTGAACTCCTGGGCTTAAGCA 721 GTCCTGCCTCGGCTTCCCAAAATGCTAGGATTAGAGCCACCATGCCCAGCCTATTTTGATTTTTGTTTTTTTATGTTCCT 801 TTCTAATAAATTGTAACAAATGATGTTCTCAAGTACATTTCCAGTTTCTTTTCTTTTCTTTCTTTTTTTTTTTTTTTTTT 881 TTTTTGAGATGGAGTCTCGCTCTATCGCCCAGGCTGGAGTGCAGTGGCGCGATCTTGGCTCACTGCAAGCTCTACCTCCT 961 GGGTTCACACCATTCTCCTGCCTCAGCCTCCCAAGTAGCTGGGACTACAGGCGCCTGCCACCATGCCTGGCTAATTTTTA 1041 GTAGAGACGGGGTTTCGCAGTGTTAGCCAGGAAGGTCTCAATCTCCTGACCTCCTGATCCGCCCGCCTCGGCCTCCCAAA 1121 GTGCTGGGATTACAGGCGTGAGCCACCGCGCCCAGTTGTGCATTTCTGGTTTCTAAGAATCAAACCACTTGGCTGTTTTT 1201 AGGAGTTACTTCCCATGTTATAAAGCTGAGGAAGCTTTTTTTTTTTTTTTTTGAGACAGAGTCTCTGTCACCCAGGCTGG 1281 AGTGCAGTGGTGCAATCTCAGCTCCCGGGTTCAAGCAATTCTCCTGCCTCAGCCTTCTGAGTAGCTAAGATTACAGGTGT 1361 GCGCCAACACGTCTGGCTTATTTTTTTGTATTTTTAGTAGAGATGGAGTTTCACCATGTTGGTCAGGTGGGTCTCAAACT 1441 CCTGACCTCAAGTGATCCGCCCATCTCCTCCCAAAGTGCTGGATTGCAGGCATGAGCGCCTAGCCAGGAAGCTATCTTTT 1521 CTTGAGTTATGAAACTTTGCAACAGTTGTTCAAATTGGTGTTTGTCCTTCCTATAGCTTTCATATTTTCAAATTAATTCT 1601 GTATGGCTATATAATTTATGTTTTAAAAGGCAATTCTCTTGACTTTGGAAATATGGAAGTCTCTCCTTTAACCTATTCTT 1681 GTTCCCATTCCCAGTCTCATTTGAAATCATTCCTTTTATTGTTAGTGTGTGTATTTTTGTTGGTGTGCTTTTAATGCATC 1761 CAAGTATGCATCATTTTGGATAAAAAATACATCCAAATTAAGATGTTTTAACACATAGGACAAACTTGTGCACTTTTTAT 1841 GCCAAAAAAAAAAAAAATTGGGTTTTCCTTCATGGGATTTCTAGAAACACTGCCTACACTTTATGAAAACTACATAGTAT 1921 TCACCTGTGACAGGTAGAGTTTATCACTATTAATTTTATGAGGCTATTTATTACTTTCCAATGCATCCACTTAGAACAAG 2001 CTAAGAGTAAGGCTGCTAACTTTAATTCCTTGCCTGATTTTATTGTACAGTGTGCACAAGCACAATGGTATGCTTGTATA 2081 TAGAAACTAAAAATACTATGAAGTACATAAGTTCCCTATGGCTTATGGAGAGTTATTTATTAATTAACTTTATGGTAGGG 2161 CTAGTATGAATACCTTTTTAACAATTGTGTGCTATTACAACAATGAAGATTCAAATGACTCCGCTTTGAAGGATGTTTTC 2241 TCTATATGGTAAAATATATATGAAGAAGTCTTGATTACGTGAAGATCACTTGACTCAGAATACTTCAATGTATTTTGTTC 2321 ACATTACCACTAAGCATATTATCAGTAAACTATTAACTGACTGCACATTATGTAATACGTTGTACTTTTTGTTGAATTCA 2401 CCGAAGTTCTTCCATTTATATGCTATTTTTAATGGCATTCCGGCTTTAACATTCTGTGAGTCTTACAAATTTGACTCTTG 2481 AATGGCAAAATAATGTTAGTATGTAGAAGGTTAACTTTCATTTATAATATAAGTGGTGCAGGGGTTCAACATTTTAAGTA 2561 AAAATATTTTTACACACTACCTCTCTCTTTTTTTTTTTAAAGTTTTAACATCAGAACTTTTGGGGGAAAAACTACTTCAG 2641 GGCTTGACTTTTTGTACAAATTTTAACTGTAAAATACAGATTTATCTTGTACGCATTCATGGAAATGGAAATCAAAGCTG 2721 CTATTGCTTTTTATTTTAATTATCCTGTTAAGGGTATCTATCAATGGTATTTTCAAGTAGATCTCTGTTTCTTAAATTAT 2801 TGGTGAAATAATTGATTACTAGATATATTGTAAAACCAATAGATCCTGGTTATACGATAAAATATCAGCTCATTGGTAGG 2881 CTGAATCAATTATTTCAAGTGCACCTTATTAACAAAAGTATCAGTGGATCCAACATAAAATTTTATAGTACTAAATGTCA 2961 AGCCTAACTGTGAATTTTGTTCTGTATCTTAAGTAAATTTATGATAATGTTCTCGAGCTATCAACAAAATATATGTACTT 3041 TTGTGAGCTATGAATTTTCTAATTAAATTTTACATGCTATAACATGATTTTTACATGAATGATACTTTGTTTATAACTAT 3121 CAAATGTCAGTATTTTACTACAATTTTATTATAAAGTGTACATTATCACTAAATGAACTTCGATTTTAAAAATCAAATTA 3201 GCTTTAGTTGTATATTATTTTTTACAAATAAAGATAGACTTGTATAAAGGCTAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545212. RNA binding protein: AGO1. Condition:Control
PAR-CLIP data was present in GSM545214. RNA binding protein: AGO3. Condition:Control
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
PAR-CLIP data was present in GSM545217. RNA binding protein: AGO2. Condition:miR-7 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 84612.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065667. RNA binding protein: AGO1. Condition:4-thiouridine
"PAR-CLIP data was present in GSM1065670. RNA binding protein: AGO2. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Prostate Tissue |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRX1760632. RNA binding protein: AGO2. Condition:AGO-CLIP-22RV1_C
... - Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al., 2016, Neoplasia (New York, N.Y.). |
Article |
- Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al. - Neoplasia (New York, N.Y.), 2016
MicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and metastatic progression. To comprehensively define the cancer-associated changes in miRNA targeting and function in commonly studied models of PCa, we performed photoactivatable ribonucleoside-enhanced cross-linking immunoprecipitation of the Argonaute protein in a panel of PCa cell lines modeling different stages of PCa progression. Using this comprehensive catalogue of miRNA targets, we analyzed miRNA targeting on known drivers of PCa and examined tissue-specific and stage-specific pathway targeting by miRNAs. We found that androgen receptor is the most frequently targeted PCa oncogene and that miR-148a targets the largest number of known PCa drivers. Globally, tissue-specific and stage-specific changes in miRNA targeting are driven by homeostatic response to active oncogenic pathways. Our findings indicate that, even in advanced PCa, the miRNA pool adapts to regulate continuing alterations in the cancer genome to balance oncogenic molecular changes. These findings are important because they are the first to globally characterize miRNA changes in PCa and demonstrate how the miRNA target spectrum responds to staged tumorigenesis.
LinkOut: [PMID: 27292025]
|
CLIP-seq Support 1 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_032521 | 3UTR | UAUUGGUGAAAUAAUUGAUUACUAGAUAUAUUGUAAAACCAAUAGAUCCUGGUUAUACGAUAAAAUAUCAGCUCAUUGGUAGGCUGAAUCAAUUAUUUCAAGUGCACCUUAUUAACAAAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_032521 | 3UTR | UUGGUGAAAUAAUUGAUUACUAGAUAUAUUGUAAAACCAAUAGAUCCUGGUUAUACGAUAAAAUAUCAGCUCAUUGGUAGGCUGAAUCAAUUAUUUCAAGUGCACCUUAUUAACAAAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_032521 | 3UTR | AUAAUUGAUUACUAGAUAUAUUGUAAAACCAAUAGAUCCUGGUUAUACGAUAAAAUAUCAGCUCAUUGGUAGGCUGAAUCAAUUAUUUCAAGUGCACCUUAUUAACAAAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_032521 | 3UTR | UAGAUAUAUUGUAAAACCAAUAGAUCCUGGUUAUACGAUAAAAUAUCAGCUCAUUGGUAGGCUGAAUCAAUUAUUUCAAGUGCACCUUAUUAACAAAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_032521 | 3UTR | UUAUACGAUAAAAUAUCAGCUCAUUGGUAGGCUGAAUCAAUUAUUUCAAGUGCACCUUAUUAACAAAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_032521 | 3UTR | AUAUUGUAAAACCAAUAGAUCCUGGUUAUACGAUAAAAUAUCAGCUCAUUGGUAGGCUGAAUCAAUUAUUUCAAGUGCACCUUAUUAACAAAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM545212 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000371610.2 | 3UTR | AAUCAAUUAUUUCAAGUGCACCUUAUUAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset GSM545214 | |
---|---|
Method / RBP | PAR-CLIP / AGO3 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000371610.2 | 3UTR | AAUCAAUUAUUUCAAGUGCACCUUAUUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 9 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000371610.2 | 3UTR | AAUCAAUUAUUUCAAGUGCACCUUAUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 10 for dataset GSM545217 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-7 transfection |
Location of target site | ENST00000371610.2 | 3UTR | AAUCAAUUAUUUCAAGUGCACCUUAUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 11 for dataset GSM1065667 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_6 |
Location of target site | ENST00000371610.2 | 3UTR | AAUCAAUUAUUUCAAGUGCACCUUAUUAACAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 12 for dataset GSM1065670 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / 4-thiouridine, 3_ML_LG |
Location of target site | ENST00000371610.2 | 3UTR | AAUCAAUUAUUUCAAGUGCACCUUAUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
58 hsa-miR-569 Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT004827 | SPI1 | Spi-1 proto-oncogene | ![]() |
![]() |
2 | 1 | ||||||
MIRT086537 | HSPE1-MOB4 | HSPE1-MOB4 readthrough | ![]() |
![]() |
2 | 2 | ||||||
MIRT086545 | MOB4 | MOB family member 4, phocein | ![]() |
![]() |
2 | 2 | ||||||
MIRT154349 | PARD6B | par-6 family cell polarity regulator beta | ![]() |
![]() |
2 | 4 | ||||||
MIRT182174 | POU2F1 | POU class 2 homeobox 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT190452 | EIF5 | eukaryotic translation initiation factor 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT191410 | NAA30 | N(alpha)-acetyltransferase 30, NatC catalytic subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT199846 | CSNK1G2 | casein kinase 1 gamma 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT208376 | SLC25A36 | solute carrier family 25 member 36 | ![]() |
![]() |
2 | 2 | ||||||
MIRT275677 | CARKD | NAD(P)HX dehydratase | ![]() |
![]() |
2 | 2 | ||||||
MIRT275764 | TFDP1 | transcription factor Dp-1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT280470 | UBR7 | ubiquitin protein ligase E3 component n-recognin 7 (putative) | ![]() |
![]() |
2 | 2 | ||||||
MIRT296592 | FAM217B | family with sequence similarity 217 member B | ![]() |
![]() |
2 | 4 | ||||||
MIRT306847 | FYTTD1 | forty-two-three domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT443764 | HLF | HLF, PAR bZIP transcription factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT448026 | GSR | glutathione-disulfide reductase | ![]() |
![]() |
2 | 2 | ||||||
MIRT448659 | NCALD | neurocalcin delta | ![]() |
![]() |
2 | 2 | ||||||
MIRT449142 | UQCRB | ubiquinol-cytochrome c reductase binding protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT449225 | RAD51B | RAD51 paralog B | ![]() |
![]() |
2 | 2 | ||||||
MIRT462421 | TWISTNB | TWIST neighbor | ![]() |
![]() |
2 | 2 | ||||||
MIRT468478 | SESN3 | sestrin 3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT478170 | DENND5B | DENN domain containing 5B | ![]() |
![]() |
2 | 2 | ||||||
MIRT478577 | VSIG2 | V-set and immunoglobulin domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT481300 | ATP5G3 | ATP synthase, H+ transporting, mitochondrial Fo complex subunit C3 (subunit 9) | ![]() |
![]() |
2 | 16 | ||||||
MIRT485894 | ZFP36 | ZFP36 ring finger protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT497242 | FITM2 | fat storage inducing transmembrane protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT500282 | ZNF703 | zinc finger protein 703 | ![]() |
![]() |
2 | 8 | ||||||
MIRT509536 | RSBN1L | round spermatid basic protein 1 like | ![]() |
![]() |
2 | 4 | ||||||
MIRT511835 | GPATCH8 | G-patch domain containing 8 | ![]() |
![]() |
2 | 4 | ||||||
MIRT522437 | MON1B | MON1 homolog B, secretory trafficking associated | ![]() |
![]() |
2 | 2 | ||||||
MIRT523538 | GLO1 | glyoxalase I | ![]() |
![]() |
2 | 4 | ||||||
MIRT527631 | MYBPC1 | myosin binding protein C, slow type | ![]() |
![]() |
2 | 4 | ||||||
MIRT528059 | OLAH | oleoyl-ACP hydrolase | ![]() |
![]() |
2 | 2 | ||||||
MIRT532549 | TXNL1 | thioredoxin like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT545503 | NAP1L1 | nucleosome assembly protein 1 like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT546724 | RNF6 | ring finger protein 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT546737 | RNF141 | ring finger protein 141 | ![]() |
![]() |
2 | 2 | ||||||
MIRT550889 | ACTA1 | actin, alpha 1, skeletal muscle | ![]() |
![]() |
2 | 2 | ||||||
MIRT554180 | SLC35E2B | solute carrier family 35 member E2B | ![]() |
![]() |
2 | 2 | ||||||
MIRT555878 | PAFAH1B2 | platelet activating factor acetylhydrolase 1b catalytic subunit 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT558458 | DCUN1D1 | defective in cullin neddylation 1 domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT560375 | TIMM8A | translocase of inner mitochondrial membrane 8A | ![]() |
![]() |
2 | 2 | ||||||
MIRT562672 | AKT3 | AKT serine/threonine kinase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT563810 | TUBA1B | tubulin alpha 1b | ![]() |
![]() |
2 | 2 | ||||||
MIRT564607 | ZNF711 | zinc finger protein 711 | ![]() |
![]() |
2 | 2 | ||||||
MIRT564881 | YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon | ![]() |
![]() |
2 | 2 | ||||||
MIRT566724 | MSL2 | MSL complex subunit 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT566900 | CSRP3 | cysteine and glycine rich protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT570002 | COL1A2 | collagen type I alpha 2 chain | ![]() |
![]() |
2 | 2 | ||||||
MIRT612300 | ZFP14 | ZFP14 zinc finger protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT618334 | ZNF813 | zinc finger protein 813 | ![]() |
![]() |
2 | 2 | ||||||
MIRT627658 | RSBN1 | round spermatid basic protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT630660 | PLAG1 | PLAG1 zinc finger | ![]() |
![]() |
2 | 2 | ||||||
MIRT640802 | MYCL1 | MYCL proto-oncogene, bHLH transcription factor | ![]() |
1 | 1 | |||||||
MIRT651370 | ZBTB21 | zinc finger and BTB domain containing 21 | ![]() |
![]() |
2 | 2 | ||||||
MIRT709227 | GPSM2 | G protein signaling modulator 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT712058 | ZBTB34 | zinc finger and BTB domain containing 34 | ![]() |
![]() |
2 | 2 | ||||||
MIRT725006 | ZPBP | zona pellucida binding protein | ![]() |
![]() |
2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|